The Phase 3 D1AMOND Study of Adults, Adolescents, and Children with Tourette's Disorder

Scientists are investigating a study drug called ecopiam for adults, adolescents, and children with Tourette's Disroder. A study drug is one that is not yet approved for use by the general public. Ecopipam is designed to function differently than the currently approved therapies for individuals with Tourette's Disorder. Schentists want to find out how it works over time and how safe it is for children, adolescents, and adults with Tourette's Disorder. For more information please email sandra.skinner@stonybrookmedicine.edu or call 631-444-7513.